Microbiogical data, but not procalcitonin improve the accuracy of the clinical pulmonary infection score
- 9 March 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Intensive Care Medicine
- Vol. 36 (5), 790-798
- https://doi.org/10.1007/s00134-010-1833-5
Abstract
Objective Early and adequate treatment of ventilator-associated pneumonia (VAP) is mandatory to improve the outcome. The aim of this study was to evaluate, in medical ICU patients, the respective and combined impact of the Clinical Pulmonary Infection Score (CPIS), broncho-alveolar lavage (BAL) gram staining, endotracheal aspirate and a biomarker (procalcitonin) for the early diagnosis of VAP. Design Prospective, observational study Setting A medical intensive care unit in a teaching hospital. Patients Over an 8-month period, we prospectively included 57 patients suspected of having 86 episodes of VAP. Intervention The day of suspicion, a BAL as well as alveolar and serum procalcitonin determinations and evaluation of CPIS were performed. Measurements and main results Of 86 BAL performed, 48 were considered positive (cutoff of 104 cfu ml−1). We found no differences in alveolar or serum procalcitonin between VAP and non-VAP patients. Including procalcitonin in the CPIS score did not increase its accuracy (55%) for the diagnosis of VAP. The best tests to predict VAP were modified CPIS (threshold at 6) combined with microbiological data. Indeed, both routinely twice weekly performed endotracheal aspiration at a threshold of 105 cfu ml−1 and BAL gram staining improved pre-test diagnostic accuracy of VAP (77 and 66%, respectively). Conclusion This study showed that alveolar procalcitonin performed by BAL does not help the clinician to identify VAP. It confirmed that serum procalcitonin is not an accurate marker of VAP. In contrast, microbiological resources available at the time of VAP suspicion (BAL gram staining, last available endotracheal aspirate) combined or not with CPIS are helpful in distinguishing VAP diagnosed by BAL from patients with a negative BAL.This publication has 49 references indexed in Scilit:
- Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumoniaEuropean Respiratory Journal, 2008
- Diagnosis of ventilator-associated pneumonia: a systematic review of the literatureCritical Care, 2008
- Antibiotic Treatment of Exacerbations of COPD: A Randomized, Controlled Trial Comparing Procalcitonin-Guidance With Standard TherapySocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2007
- Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*Critical Care Medicine, 2006
- Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-analysisClinical Infectious Diseases, 2004
- Empirical antimicrobial therapy of septic shock patients: Adequacy and impact on the outcome*Critical Care Medicine, 2003
- Alveolar and Serum ProcalcitoninAnesthesiology, 2002
- Levels of three inflammation markers, C-reactive protein, serum amyloid A protein and procalcitonin, in the serum and cerebrospinal fluid of patients with meningitisScandinavian Journal of Clinical and Laboratory Investigation, 2001
- Diagnosis of Ventilator-associated PneumoniaAnesthesiology, 1997
- A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter studyJAMA, 1993